If you'd like to claim this company profile for Sun Pharma, please
Contact Us.
Sun Pharma News
The latest news, announcements and press releases from Sun Pharma.
Sun Pharma to Acquire Concert Pharmaceuticals for $576M
Adds Deuruxolitinib, a potential best-in-class oral JAK inhibitor for the treatment of alopecia areata.
Read the full story »
Sun sales in U.S. fall further as FDA issues linger
India's Sun Pharmaceutical saw its sales in the U.S., its largest market, continue to fall as problems with a key plant in India have yet to be resolved. U.S. sales were off 11% to $486 million in the quarter ended Dec. 31, 2015, India's largest drugmaker reported today.
Read the full story »
Sun to launch copy of Novartis' best-selling drug Gleevec Feb. 1
The day of reckoning is on the books for Novartis' ($NVS) top-selling drug, cancer pill Gleevec. Sun Pharma said today that the FDA has approved its generic of the blockbuster and that it will launch its version in two months, beginning Feb. 1.
Read the full story »
Sun Pharmaceutical Industries Shares Sink on FDA Warning Letter
Sun Pharmaceutical shares fell as much as 7.5 per cent to Rs 731 after India's biggest drugmaker disclosed that it has received a "warning letter" from US regulator over violation of manufacturing standards at its Halol plant in Gujarat, which is its largest manufacturing facility.
Read the full story »
Claim This Profile
This is the News section of the company profile page for
Sun Pharma on the
Pharmaceutical Services Directory. Companies listed on the directory can update their business
information free of charge. If this is your company and you'd like to claim this profile, please
Contact Us.
Sun Pharma company details, activities,
contacts and reviews.
Sun Pharma documents, images and videos.
Sun Pharma partnership and licensing
opportunities.
Sun Pharma latest news, announcements and
press releases.
Sun Pharma global factories, offices and
locations.
Sun Pharma legal and financial information.
Sun Pharma blogs, articles and journal
posts.